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Psoriasis is clinically a heterogeneous disease. Detailed evaluation of phenotype at disease onset is lacking. This
study is a baseline characterization of 400 adult individuals with ﬁrst time incidence of psoriasis on non-hairy skin,
describing clinical phenotypes and putative environmental triggers at disease onset. In total, 74 patients with
guttate and 326 patients with non-guttate phenotype, the majority with plaque psoriasis, were included. Guttate
phenotype was associated with younger age and recent infection in 84%, where acute streptococcal pharyngitis
was veriﬁed in 63%. The predominating factor associated with onset of plaque psoriasis was a recent life crisis
(46%). A positive family history for psoriasis was approximately the same in both groups. Psoriasis arthropathy
was diagnosed in 5% of guttate and 15% of non-guttate patients, with enthesopathy being the dominant symptom
among guttate patients. This study conﬁrms the strong link between onset of guttate psoriasis phenotype and
streptococcal throat infection, whereas onset of plaque psoriasis was highly associated with a preceding distinct
stressful life event. Longitudinal follow-up of the patients will provide robust information about disease devel-
opment and response to treatment.
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Psoriasis is a common, hereditary, and chronic inflamma-
tory skin disorder affecting more than 2% of the Swedish
population (Hellgren, 1967). The disease appears to be both
genetically and clinically heterogeneous, and several phe-
notypes have been described. The age at onset ranges from
early childhood to late adulthood. In a large epidemiological
study in Sweden, three peaks for age at onset were found:
at puberty, at the age of 30 y, and at the age of 50 y
(Swanbeck et al, 1995).
Epidemiological circumstances surrounding disease de-
but and the pathogenetic mechanisms inducing the pso-
riasis skin phenotype are not clear. A host of environmental
factors, however, have been incriminated in precipitating
and worsening psoriasis; including streptococcal infection
(Telfer et al, 1992; Rasmussen, 2000; Gudjonsson et al,
2003), cutaneous trauma (Eyre and Krueger, 1982), drugs
(Abel et al, 1986; Tsankov et al, 1998), alcohol and cigarette
smoking (Naldi et al, 1992; Higgins, 2000), stress (Seville,
1989; Naldi et al, 2001), and in a minority of patients, ul-
traviolet radiation (Ros and Eklund, 1987). Furthermore,
among the various factors thought to be associated with
psoriasis, a link to autoimmune disorders, such as celiac
disease, vitiligo, and autoimmune thyroid disease, has been
reported. In fact, a high prevalence of celiac disease has
been shown in patients with psoriasis (Ojetti et al, 2003).
The natural history of psoriasis has been thoroughly
studied retrospectively in various psoriasis populations. The
purpose of this study was to establish detailed baseline
characterization of adult psoriasis patients at disease onset.
The study design allows high specificity and reliable as-
sessment of clinical features, triggering factors, and age of
onset. Since ethical permission to include children was not
obtained at the time, this study comprises only individuals
above 15 y of age.
Results
Distribution of sex and age The age at onset ranged from
15 to 84 y, with a mean age of 41 (median age of 40 y).
Overall, the proportion of patients was approximately equal
in the early and late onset groups (n¼204 early onset vs
n¼196 late onset). The age patterns in the different phe-
notypes demonstrated a single distinct peak and an earlier
onset in the guttate phenotype, whereas the age at onset
occurred later among patients with non-guttate phenotype.
The sex distribution showed a slightly higher female pro-
portion, 56%.
Phenotypes The Relative frequencies of phenotypes are
shown in (Table I). In total, 400 patients were included in the
study. The largest group, regardless of age, was non-gutt-
ate psoriasis (81%, n¼326). In addition to plaque psoriasis,
Abbreviations: AGA, serum IgA antibody to gliadin; BMI, body
mass index; EmA, IgA antibodies to endomysium; PASI, psoriasis
area severity index; PGA, physician’s global assessment; RF, rheu-
matoid factors; TgA, IgA anti-transglutaminase
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the non-guttate group included palmo-plantar (n¼7), in-
verse (n¼ 5), erythrodermic (n¼1), pustular (n¼1), acro-
pustulosis (n¼ 1), and seborrhoeic (n¼1) psoriasis. But, the
small number of these phenotypes did not allow separate
analyses. Among patients with onset of plaque psoriasis,
five individuals (four females and one male) had concurrent
pustulosis palmoplantar psoriasis.
Seventy-four individuals, 18%, had a guttate phenotype
at disease onset. Guttate psoriasis was more frequently
observed in patients with early onset (78%, n¼45), where-
as patients with a non-guttate phenotype were approxi-
mately equally distributed in the two age groups (45% early
vs 55% late onset). In this material, patients with guttate
phenotype were significantly younger than those with non-
guttate phenotype (po0.001).
Facial involvement occurred in 17% of patients (n¼ 66)
and was slightly more common among guttate patients
(20% guttate vs 16% of non-guttate patients). Among non-
guttate patients, facial lesions occurred more often in
younger individuals, whereas there was no difference be-
tween age groups in patients with guttate phenotype.
The Ko¨bner phenomenon was observed in 5% of all pa-
tients (n¼20), of whom more than half (n¼11) had early
onset of guttate phenotype, probably indicating a more
eruptive and active form of onset.
Forty percent of patients (n¼158) reported pruritus as-
sociated with psoriasis, occurring equally among groups.
Psoriasis area severity index (PASI) and physician’s
global assessment (PGA) We used PASI and PGA meth-
ods in parallel to assess the severity of cutaneous involve-
ment. We observed a high level of concordance for the two
methods. The average time span from disease onset to skin
examination was 4 mo for guttate patients and 7 mo for
non-guttate patients. Most patients were without active
treatment at the time of examination. But, less than 4% of
patients (n¼14), with equal sex distribution, had received
systemic treatment before examination. A minority of pa-
tients (4%, n¼ 14) were in remission at the time of entry. In
these patients, the diagnosis was secured from medical
records and patients were followed up at our clinic to as-
certain the diagnosis. Overall, approximately 60% of the
patients were evaluated as having mild disease, whereas
more than one-third had moderate and only 3%–5% had
severe psoriasis at examination.
Table I. Clinical characterization of psoriasis phenotype at onset in relation to environmental factor
Guttate (%) Non-guttate (%)
Total (%) (n¼400)p40 (n¼58) 440 (n¼16) p40 (n¼146) 440 (n¼ 180)
Sex
Female 52 62 51 61 56
Clinical examination
Skin
Phenotype 78 22 45 55
Combined witha
þ face 21 19 23 9 17
þnail 3 — 8 19 12
þKo¨bner phenomenon 19 6 3 2 5
Joints
Arthritisa 5 6 15 17 14
DIP predominant — — — 1
Symmetric oligoarthritis — — 1 2
Asymmetric polyarthritis 4 6 11 14
Spondylitis 4 — 7 8
Peripheral enthesopathyb 2 12 3 8 5
Precipitating factors
Unknown 4 6 37 39 32
Only life crisisc 12 13 44 48 40
Only infectionsd 57 62 11 8 18
Infectionþ life crisis 27 19 8 5 10
aNot mutually exclusive, why it adds up to 4100%.
bWithout arthritis.
cSevere event profoundly affecting life with 2 mo prior to psoriasis onset, without ongoing infections.
dWithout life crisis.
DIP, distal interphalangeal.
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Nail involvement Finger nail involvement was detected in
12% of patients (n¼ 47), the majority, 96% (n¼45), being of
the non-guttate phenotype. Nail changes were also more
frequent in patients with late-onset psoriasis (17% late vs
early onset 6%, po0.001). There was no significant corre-
lation between nail involvement and psoriasis arthropathy or
PASI score in this study. Most nail changes were estimated
as mild. But, 1% (n¼ 5) had severe nail involvement, all of
whom were of non-guttate phenotype with late onset.
Psoriasis arthropathy Overall, 14% of patients (n¼ 54)
had psoriasis arthritis with or without enthesopathy at dis-
ease onset. Five percent of patients (n¼ 21) had only en-
thesopathy without arthritis (Table I). The majority of patients
with arthritis were found among the non-guttate patients,
whereas enthesopathy was equally common among
patients with guttate psoriasis (Table I).
Associated environmental factors The relative frequency
of potential disease triggers is shown in (Table I). In total,
113 patients (28%) had a positive history of infection (with
or without life crisis) preceding psoriasis onset. The most
frequent infection was streptococcal pharyngitis, which was
the most common precipitating factor for patients with
guttate phenotype. Overall, 84% of patients with guttate
psoriasis (n¼62) had a history of infection (with or without
life crisis) prior to occurrence of skin lesions, and the ma-
jority of these patients (n¼46) had a verified streptococcal
pharyngitis. Only 7% of patients (n¼23) with non-guttate
phenotype had verified streptococcal pharyngitis. Thus,
streptococcal pharyngitis was almost nine times more com-
mon in patients with guttate than in non-guttate psoriasis
(po0.001).
The most common precipitating factor for patients in
the non-guttate category, without streptococcal pharyngitis,
was a life crisis within 2 mo prior to disease onset.
Family history of psoriasis Overall, complete information
about family history was available in 378 patients (95%). Of
the 22 individuals who lacked information, four were adopt-
ed and 18 lacked information about the complete family,
usually missing information about one parent (Table II).
Among individuals in whom information was available,
52% reported a positive family history of psoriasis, includ-
ing first-, second-, and third-degree relative/s. Thirty-four
percent (126/378) indicated the presence of psoriasis in at
least one first-degree relative. The minimum estimate for the
cases was 32% for a positive family history in a first-degree
relative, if all cases were considered in the denominator
(126/400). Positive family history in a first-degree relative
was approximately the same for guttate, 30% (n¼ 22) and
non-guttate, 35% (n¼ 127) individuals. Among patients with
psoriatic arthropathy, irrespective of skin phenotype, 27%
(20/75) had a first-degree relative with psoriasis. Thus, in
our study, positive family history was comparable among
different clinical phenotypes at onset and did not affect the
expression of psoriasis arthropathy.
Co-morbidity A summary of concomitant diseases in the
study population is presented in Table S1. No patient had
ongoing atopic eczema, but a history of previous flexural
dermatitis in childhood was present in all groups and was
most pronounced in young patients with a guttate phe-
notype. Other atopic manifestations were present in all
groups.
As expected, cardiovascular diseases, in particular hy-
pertension, were mostly found among older patients. In-
creased body mass index (BMI) was observed in 30% and
obesity in 13% of patients.
The prevalence of celiac disease was approximately 1%
in patients. Biopsy from the small intestine verified celiac
disease in four of the patients.
Laboratory analyses Total serum IgA was elevated in 12%
of guttate patients (n¼9) compared with 8% of non-guttate
patients (n¼25). The proportion of patients who had in-
creased serum IgA levels did not differ between patients
with or without arthritis.
Serum levels of serum IgA antibody to gliadin (AGA) did
not differ between phenotypes, but there was a gender dif-
ference, with 6% of the women being positive and only 3%
of the men.
Overall, IgM rheumatoid factor (RF) was elevated in eight
patients (2%). The highest prevalence of RF was found
among older patients with a non-guttate phenotype (seven
individuals) and of these, three were previously diagnosed
with rheumatoid arthritis, one patient had psoriasis erythro-
dermia with psoriasis arthritis, and the remaining three had
no joint problems. Among guttate patients, only one had
positive RF and this patient had no joint complaint and was
below 40 y of age.
Discussion
This study represents a unique effort to characterize adult
psoriasis patients with regard to phenotype and precipitat-
ing factors at the onset of disease.
To reduce problems of generalization, patients were re-
cruited through multiple channels, including self-referral.
Despite these efforts, one may question whether the pa-
tients are representative for psoriatic patients in general. It is
likely that patients with a high degree of concern and with a
more acute onset of disease, especially when associated
with an infection, might be more prone to seek health care
than patients with a more insidious onset. This may explain
Table II. Family history of psoriasis
Guttate (%) Non-guttate (%)
Total (%) (n¼400)p40 (n¼ 57) 440 (n¼ 16) p40 (n¼138) 440 (n¼ 167)
First-degree relative/s 32 25 38 31 34
Second and third-degree relative/s 18 19 22 16 18
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the relatively high proportion of patients with a guttate phe-
notype in this study, 19%, compared with 14% reported
previously in adult psoriasis in Sweden (Molin, 1973). Then
again, according to the study design, we have included
patients consecutively without any restrictions concerning
disease severity, whereas the previous study included only
patients who required hospitalization because of their pso-
riasis. Also, the female dominance (approaching 1.3:1) in
this study may reflect sex-related preference in seeking
health care (Health and Medical Care 1980–2000, 2002),
whereas, previous reports have observed either an equal
sex distribution or a male predominance among patients
with psoriasis.
Likewise, prior knowledge about psoriasis and presence
of psoriasis in the family, and campaigns on the website and
magazine of the Swedish Psoriasis Association may influ-
ence the inclination to seek medical advice at an early stage
and render individuals who are familiar with psoriasis more
willing to participate. This may explain why we record a
higher familial occurrence of psoriasis among patients with
late onset compared with previous studies (Henseler and
Christophers, 1985; Ferrandiz et al, 2002). A detailed analysis
of the familial tendency to develop psoriasis is not the focus
of this study and thus, we do not account for differences in
family size and number of affected family members.
Our results indicate that the dominant precipitating factor
for non-guttate phenotype is a recent distinct life crisis. The
association between onset and exacerbation of psoriasis
with stress is much debated and previous studies point in
different directions. A recent study comprising 40 patients
with mixed psoriasis phenotypes showed no evidence for
an influence of stressful life events on psoriasis symptoms
(Picardi et al, 2003), whereas other studies suggest a link
between psycho-social stress and both onset and exacer-
bation of psoriasis (Naldi et al, 2001; Fortune et al, 2003).
Obviously, more epidemiological and experimental research
is needed to understand this potentially key issue in ex-
pression of psoriasis phenotype. In this study, clinical ex-
amination and evaluation of patient history occurred in
association with disease debut, which is likely to substan-
tially increase the reliability of information and thus support
the relationship between a life crisis and the expression of
plaque psoriasis lesions.
In patients with guttate psoriasis, we confirm and
strengthen the solid link between streptococcal pharyngitis
and guttate onset (Telfer et al, 1992; Leung et al, 1995; Valdi-
marsson et al, 1995). We must acknowledge, however, that
the time lead between onset of skin symptoms and clinical
examination was shorter in guttate patients, which may partly
influence the identification of streptococcal infection.
Among patients with a guttate phenotype, three patients
presented with cutaneous infection, where we confirmed
the presence of streptococcus pyogenes in the skin but not
in the throat. Evidently, the association between psoriasis
onset and streptococci is not confined to mucosal involve-
ment, even though it is by far the most common location.
Nail involvement was more common among patients with
non-guttate phenotype and was 2.5 times more frequent in
the older age group compared with the group with early
onset. These findings seemingly disagree with earlier stud-
ies, which indicate a positive correlation between nail pso-
riasis and early onset of disease (Ferrandiz et al, 2002;
Stuart et al, 2002). These reports, however, describe pso-
riasis patients with highly variable disease duration and the
results may reflect the positive association between nail
psoriasis and duration of skin lesions as has previously
been suggested (de Jong et al, 1996).
Psoriasis arthritis was diagnosed in 13.5% (n¼54) of all
patients and was more common among patients with a non-
guttate phenotype in accordance with previous reports (Fe-
rrandiz et al, 2002). The standardized clinical examination of
all patients reporting any degree of joint complaints may
have precipitated the diagnosis of psoriasis arthropathy in
patients with mild disease not spontaneously seeking
rheumatologic care, thus maximizing the association. En-
thesopathy without manifest arthritis was diagnosed in 5%
of all patients and was also found among young patients
with guttate psoriasis. Follow-up of these patients is re-
quired to assess to which extent the enthesopathy reflects
an acute self-limiting reaction or will develop into manifest
arthritis and to which extent the joint symptoms will parallel
the skin disease.
Information about co-morbidity at onset of psoriasis is
lacking. Multiple studies indicate a low prevalence of atopic
eczema in psoriasis patients (Christophers and Henseler,
1987; Henseler and Christophers, 1995). Our present data,
however, indicate that a history of childhood atopic eczema
is not uncommon among patients with a guttate phenotype.
Guttate psoriasis represents a more volatile eczematous
inflammatory reaction than plaque psoriasis and one could
speculate whether patients who present with guttate pso-
riasis may be inherently prone to developing acute inflam-
matory skin responses. Interestingly, recent genetic data
point to partially overlapping candidate loci between
psoriasis and atopic eczema, which may suggest shared
underlying pathomechanisms (Speckman et al, 2003;
Bowcock and Cookson, 2004).
Increased cardiovascular morbidity is reported in pso-
riasis and epidemiological data suggest that the risk for
cardiovascular disease is more pronounced in severe pso-
riasis (Henseler and Christophers, 1995; Poikolainen et al,
1999; Mallbris et al, 2004). As expected, the prevalence of
cardiovascular disease in this study was mostly confined to
the older age group. Previous studies suggest that one
established risk factor for cardiovascular disease, namely an
elevated BMI, is higher in patients than in the control pop-
ulation controls, underlining the potential metabolic aspect
of psoriasis (Lindegard, 1986; Henseler and Christophers,
1995). Whether the diagnosis of psoriasis will produce di-
vergent development in BMI over time will be an interesting
issue to be followed.
Increased levels of autoantibodies toward gliadin have
previously been demonstrated in psoriasis and psoriasis
arthritis (Michaelsson et al, 2000; Lindqvist et al, 2002; Ojetti
et al, 2003). In this study, we detected higher levels of AGA
among patients with late onset. Since previous studies re-
port on patients with highly variable disease duration, it will
be interesting to see whether significant differences will
emerge and if so whether they are associated with distinc-
tive phenotypic traits.
This study represents the initial baseline description of
adult psoriasis patients examined within 1 y after onset of
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skin lesions. The sample size is not sufficient to detect as-
sociation with rare disorders at this point. But, additional
patients are being recruited along with population-matched
controls and the first follow-up of patients, at 4 y after onset,
is being initiated. Thus, these patients form the basis for a
biobank allowing for genetic and molecular studies and
longitudinal follow-up, which will create robust knowledge
about psoriasis development, associated co-morbidities,
and potential epidemiological links.
Material and Methods
Patients Patients above 15 y of age with onset of psoriasis lesions
on non-hairy skin within the past 12 mo were eligible to enter
the study. Patients were seen consecutively by two dermatologists
(L. M., M. S.), at the department of Dermatology, Karolinska
Hospital, Stockholm, Sweden, between 2001 and 2003. Individuals
with a previous diagnosis or a history of skin lesions compatible
with psoriasis were excluded. Patients were classified into two
subgroups: onset p40 y, early onset, and onset 440 y, late
onset.
The study consists of 400 patients, 175 males and 225 females,
mainly originating from Sweden and mostly recruited from the
Stockholm area through the advertisements in two different
free-distributed daily newspapers, campaigns on the website
and magazine of the Swedish Psoriasis Association, referrals
from private dermatologists, other dermatology clinics, general
practitioners, school nurses, sexual health centers, and youth
clinics.
In total, 950 individuals either responded or were referred. Prior
to clinical examination, a telephone interview was conducted by
the examining physician or an experienced nurse trained in pso-
riasis. Four hundred and twenty individuals were examined clini-
cally, of which 400 were eligible to enter the study. Only subjects
with a clinically convincing diagnosis of psoriasis were included.
Patients were classified according to the pattern and severity of
psoriasis lesions on skin, presence or absence of nail involvement,
and psoriasis arthropathy at the time of initial examination. All in-
dividuals with any joint symptoms were examined by an experi-
enced rheumatologist (P. L.).
Additional information included a family history of psoriasis,
history of recent infections, stressful events within 2 mo prior to
onset, and other potentially predisposing factors surrounding on-
set and previous and ongoing medication. Written informed con-
sent was given by all patients. The study was approved by the
Regional Committee of Ethics. The study was performed according
to the Declaration of Helsinki Principles.
Participation Participation involved attending a clinical examina-
tion, answering a questionnaire, and providing blood samples for
laboratory analyses.
Skin examination Diagnosis and classification of psoriasis were
made using established terminology (Christophers and Sterry,
1993). Guttate psoriasis was defined as acute onset of scattered
small coin-like lesions. Non-guttate psoriasis included nummular
and large plaque type. Single patients with other distinct pheno-
types were also recruited.
Measurement of skin disease severity was performed using
both PASI and PGA in parallel. A PASI score below 3 was defined
as mild, between 3 and 15 as moderate, and above 15 as severe
disease.
All medical records for subjects (3.5%, n¼ 14) who had re-
ceived psoriasis diagnosis and treatment leading to remission prior
to inclusion were requested and evaluated.
Nail examination Both fingernails and toenails were examined
clinically. But, only assessment of fingernails was taken into ac-
count, since clinical evaluation of toenails may be complicated by
frequent fungal infections.
Each nail was evaluated separately and was assigned a severity
score depending on disease activity (0¼ none, 1¼mild, 2¼mod-
erate, and 3¼ severe). The sum of the total score from all nails
gave a total score ranging between 0 and 30. The interval 0–10 was
classified as mild nail involvement, 11–20 moderate, and 21–30
severe.
The evaluation included pitting, defined as a minimum total of
two pits on a nail, onycholysis, leukonychia, hyperkeratosis, oil
drops, and crumbling.
Joint examination Patients with joint symptoms were subdivided
into five groups (Moll and Wright, 1973): patients with (1) arthritis in
distal interphalangeal joints, (2) symmetric polyarthritis, (3) asym-
metric mono-oligoarthritis, (4) spondylitis, and (5) peripheral ent-
hesopaty without arthritis. All joint evaluations were performed by
the same rheumatologist.
Associated environmental factors Associated and potentially
inducing environmental factors were recorded. Life crisis was de-
fined as a distinct severe event profoundly affecting life occurring
within 2 mo prior to disease onset, and in the absence of
streptococcal pharyngitis. Life crisis included divorce, severe/life-
threatening diseases affecting the patient or close family members,
deaths within the close family, serious financial difficulties, being
dismissed from work, and harassment at school. Infection was
defined as acute symptoms requiring antibiotics or antiviral treat-
ment (one case) occurring up to 10 d before onset of psoriasis.
Family history At inclusion, a family history was carefully ob-
tained by the examining dermatologist. A diagnosis of psoriasis in
any first- (biological parents, siblings and children), second- (bio-
logical grandparents, grandchildren, uncles, and aunts), or third-
(biological first cousins) degree relative/s was recorded.
Laboratory analyses
IgA antibody to gliadin and RF AGA, reference o50 U per liter,
total serum IgA (reference 07–4.5 g per liter), IgA antibodies to
endomysium (EmA), IgA anti-transglutaminase (TgA), and IgM RF
were measured in all patients, using routine laboratory methods.
Seropositivity for IgM RF was defined as a Waaler–Rose titer of 40
or more (Husby et al, 1988).
All individuals (n¼ 5) positive for EmA and/or TgA in serum un-
derwent endoscopic evaluation including biopsies from the small
intestine. Specimens were evaluated by a pathologist for severe to
total villous atrophy, crypt hyperplasia, and lymphocyte infiltration
to confirm celiac disease.
Streptococcal throat infection A throat-swab for culture as a diag-
nostic test for streptococcal infection was obtained from all pa-
tients.
BMI BMI was calculated for all patients. Increased BMI was de-
fined as a BMI between 25 and 30 kg per m2 and obesity as a BMI
above 30 kg per m2 (Bray, 1987).
Statistical analyses Comparison between guttate and non-guttate
with respect to clinical manifestations, precipitating factors, family
history, and co-morbidity was performed by Fisher’s exact test.
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Table S1. Co-morbidity in psoriasis at onset
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